Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Indian J Pharmacol ; 51(1): 72-74, 2019.
Article in English | MEDLINE | ID: mdl-31031470

ABSTRACT

The distressing consequences of immunology in leprosy is the lepra reaction. Erythema nodosum leprosum(ENL) in special cases need to be managed with capsule thalidomide in varying doses. We report such a case of bradycardia in thalidomide dose dependent manner in a young ENL male.


Subject(s)
Bradycardia/chemically induced , Erythema Nodosum/drug therapy , Leprostatic Agents/adverse effects , Leprosy, Lepromatous/drug therapy , Thalidomide/adverse effects , Adult , Dose-Response Relationship, Drug , Humans , Leprostatic Agents/administration & dosage , Male , Thalidomide/administration & dosage , Young Adult
2.
J Family Med Prim Care ; 7(4): 838, 2018.
Article in English | MEDLINE | ID: mdl-30234065
7.
Workplace Health Saf ; 65(8): 332, 2017 08.
Article in English | MEDLINE | ID: mdl-28746012

Subject(s)
Leprosy , Mass Screening , Humans
8.
Microb Pathog ; 104: 336-339, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28137508

ABSTRACT

Leprosy is a chronic infectious disease caused by Mycobacterium leprae. Identification of Mycobacterium leprae is difficult in part due to the inability of the leprosy bacillus to grow in vitro. A number of diagnostic methods for leprosy diagnosis have been proposed. Both serological tests and molecular probes have shown certain potential for detection and identification of Mycobacterium leprae in patients. In this study, we have investigated whether Mycobacterium leprae DNA from the nasal secretion of healthy household contacts and the non contacts could be detected through PCR amplification as a method to study the sub clinical infection in a community. A total of 200 samples, 100 each from contacts and non contacts representing all age groups and sex were included in this study. The M. leprae specific primer (proline-rich region) of pra gene was selected and PCR was performed using extracted DNA from the sample. A total of 13 samples were found to be positive for nasal PCR for pra gene among the male and female contacts out of which 7% were males and 6% were females. Even though several diagnostic tools are available to detect the cases of leprosy, they lack the specificity and sensitivity. PCR technology has demonstrated the improved diagnostic accuracy for epidemiological studies and requires minimal time. Although nasal PCR studies have been reported from many countries it is not usually recommended due to the high percentage of negative results in the contact.


Subject(s)
Asymptomatic Infections/epidemiology , Bodily Secretions/microbiology , Leprosy/diagnosis , Leprosy/epidemiology , Mycobacterium leprae/isolation & purification , Nose/microbiology , Polymerase Chain Reaction/methods , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Female , Humans , Infant , Leprosy/microbiology , Male , Middle Aged , Molecular Diagnostic Techniques/methods , Mycobacterium leprae/genetics , Sensitivity and Specificity , Time Factors , Young Adult
10.
Indian J Lepr ; 87(3): 165-8, 2015.
Article in English | MEDLINE | ID: mdl-26999989

ABSTRACT

In 1998 a 57-year-old man having skin leisons of 6 months duration reported to Central Leprosy Teaching and Research Institute (CLTRI), Chengalpattu. It was diagnosed as a case of borderline lepromatous leprosy with a type 2 lepra reaction, was treated with multi bacillary-multi drug therapy (MBMDT) for a period of 12 months and the patient was released from treatment (RFT) in September 1999. For reactions the patient was treated with prednisolone for more than 10 months. After 14 years in April 2013 the same patient presented to CLTRI with complaints of weakness of both hands with loss of sensation for 4 months, so making a diagnosis suggestive of MB relapse with neuritis the patient was started with MB-MDT for period of 12 months with initial prednisolone 25 mg OD dose then increased to 40 mg for painful swollen leg and to follow the neuritis associated pain and swelling. Increased dose is not beneficial and the patient was investigated for other pathology. Doppler ultra-sound revealed a left ileofemoral deep vein thrombosis (DVT) in that patient with levels. Prednisolone was withdrawn and the patient was started with anticoagulant heparin followed by warfarin. During this period rifampicin was also withdrawn. After patient was in good condition he was put on MB-MDT regimen. Till the 6th pulse the patient continues to show improvement in functions without steroids and any tenderness, he is taking multivitamins; regular physiotherapy. This DVT appears to be due to prednisolone and such causative relationship though rare should be kept in mind when patient on long term treatment with steroids/and or immobilized or on prolonged bed rest report with such symptomatology.


Subject(s)
Anti-Inflammatory Agents/adverse effects , Leprosy, Multibacillary/drug therapy , Prednisolone/adverse effects , Venous Thrombosis/chemically induced , Anticoagulants/therapeutic use , Heparin/therapeutic use , Humans , Leprosy, Multibacillary/complications , Male , Middle Aged , Venous Thrombosis/drug therapy , Warfarin/therapeutic use
11.
J Commun Dis ; 41(2): 81-92, 2009 Jun.
Article in English | MEDLINE | ID: mdl-22010495

ABSTRACT

An unusual increase in the incidence of viral fever was noticed in Androth and Kalpeni Island, U.T of Lakshadweep during November 2006. The Eco-epidemiology of the disease was studied in detail. The study indicated that Aedes albopictus is the predominant species (98.74%) and it exhibited a wide spectrum of breeding preferences with a clear-cut predilection for rat-damaged coconuts (RDCs). All the entomological indices were very high in both the Islands with a marked increase in Kalpeni Island. The clinical presentation of the cases was typical of chikungunya and the laboratory study confirmed this. Based on the investigation, control and preventive measures were planned, advised and implemented. The details regarding the bio-ecology of vectors, clinical presentation, laboratory investigations and effectiveness of control measures are discussed.


Subject(s)
Alphavirus Infections/epidemiology , Ecosystem , Aedes/growth & development , Aedes/virology , Alphavirus Infections/transmission , Animals , Chikungunya Fever , Female , Humans , India/epidemiology , Insect Vectors/growth & development , Insect Vectors/virology , Male , Rats
12.
J Commun Dis ; 40(1): 37-40, 2008 Mar.
Article in English | MEDLINE | ID: mdl-19127667

ABSTRACT

The mass drug administration programme to eliminate lymphatic filariasis with DEC in Kerala was started in 1997, extended to all the 11 endemic districts by 2005. Since the beginning of Mass drug Administration, the drug consumption rate was found to be not satisfactory. The reasons for noncompliance indicated that the community is not fully convinced about the programme. The knowledge of the medical and para medical workers is certainly a factor in the success of implementation of the programme and is vital. To ascertain the knowledge, a study was undertaken and found not satisfactory. Hence intensive training on all aspects of lymphatic filariasis and the Mass drug Administration programme to achieve the requisite drug consumption rate to meet the goal is needed.


Subject(s)
Clinical Competence , Elephantiasis, Filarial/prevention & control , Filaricides/administration & dosage , Health Personnel/education , Animals , Brugia/drug effects , Dose-Response Relationship, Drug , Education, Medical, Continuing , Elephantiasis, Filarial/drug therapy , Humans , India/epidemiology , Patient Compliance , Wuchereria bancrofti/drug effects
13.
J Commun Dis ; 39(1): 51-6, 2007 Mar.
Article in English | MEDLINE | ID: mdl-18338717

ABSTRACT

The Mass Annual Single dose DEC administration (MDA) was initiated in India from 1997. In Kerala MDA was studied as a pilot project in Alappuzha and Kozhikode District from 2000-04 and the first round of MDA was launched in Kerala covering eleven endemic districts, in March 2005. On evaluation, the drug distribution coverage, compliance, etc. were found to be not satisfactory and a need to elicit the factors for poor performance of MDA is felt essential. The main reasons for poor performance of MDA in Kerala state were the lack of adequate prior information to the target population regarding the importance LF elimination programme and inadequate awareness. The fear of side reactions, antipropagonda, poor IEC activities repeated postponement of programme, insufficient time for mobilisation etc. were the other reasons for poor compliance. The purpose of the present study was to bring the observations to the notice of the authorities so that appropriate remedial measures are incorporated.


Subject(s)
Diethylcarbamazine/administration & dosage , Elephantiasis, Filarial/prevention & control , Endemic Diseases/prevention & control , Filaricides/administration & dosage , Patient Compliance , Elephantiasis, Filarial/drug therapy , Humans , India/epidemiology , Knowledge , Preventive Health Services/standards , Program Evaluation/methods , Treatment Refusal
14.
J Commun Dis ; 38(4): 333-8, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17913209

ABSTRACT

The mass DEC drug administration to eliminate lymphatic filariasis in Kozhikode district was monitored from 2001 to 2003 to assess the drug distribution coverage, compliance, reasons for non-compliance, side reactions, mf prevalence and intensity, infection and infectivity rates in the vector. The drug distribution coverage and compliance were much below the required level. "No disease so not necessary" (42.5%) and "fear of side reactions" (25.2%) were the two major reasons for non-compliance. The adverse reactions were minimal. No appreciable changes were found in the mf prevalence and intensity. For the successful implementation of the MDA programme, proper planning, intense and timely efforts to motivate the community and innovative drug delivery strategies are required.


Subject(s)
Diethylcarbamazine/administration & dosage , Diethylcarbamazine/therapeutic use , Elephantiasis, Filarial/drug therapy , Elephantiasis, Filarial/prevention & control , Filaricides/administration & dosage , Filaricides/therapeutic use , Adult , Animals , Child , Culex , Diethylcarbamazine/adverse effects , Drug Administration Schedule , Female , Filaricides/adverse effects , Humans , India/epidemiology , Insect Vectors/parasitology , Male , Patient Compliance , Rural Health
15.
Indian J Lepr ; 75(4): 335-45, 2003.
Article in English | MEDLINE | ID: mdl-15242272

ABSTRACT

In India there is a dramatic fall in the prevalence rate (PR) of leprosy, but the new case-detection rate (NCDR) has not been reduced concomitantly. It is the operational efficiency of the National Leprosy Eradication Programme (NLEP) that has led to a significant reduction in the NCDR in Andhra Pradesh and Tamil Nadu. The ratio of PR to NCDR has been declining in these two states and it reveals that elimination could be reached even with the high NCDR level of 3 to 4 per 10000 population, particularly if single skin lesion (SSL) cases are discharged through single dose treatment of rifampicin, ofloxacin and minocycline (ROM). On the other hand, the significant number of cases detected in Bihar and Orissa during modified leprosy elimination campaigns (MLECs) reveals that there are lacunae in operational activities in new case-detection resulting in a large number of undetected cases in the community. Only one-third of the cases are reporting voluntarily. Awareness of leprosy is not adequate to motivate the patients to report voluntarily and complete their treatment, thus underscoring the need for relying on active case-detection so that transmission can be broken and elimination of leprosy achieved. In addition, the influence of socio-economic factors on continued occurrence of leprosy cannot be ruled out. The establishment of a sentinel surveillance system along with a computerized simplified information system to gain in-depth knowledge on the functioning of the NLEP will ensure operational efficiency. In view of this situation, the NLEP should adopt a more realistic approach towards reaching the elimination goal.


Subject(s)
Communicable Disease Control/methods , Leprostatic Agents/therapeutic use , Leprosy/epidemiology , Leprosy/prevention & control , Mycobacterium leprae/growth & development , Communicable Disease Control/standards , Drug Therapy, Combination , Female , Humans , India/epidemiology , Leprosy/drug therapy , Leprosy/microbiology , Male , Minocycline/therapeutic use , National Health Programs , Ofloxacin/therapeutic use , Prevalence , Rifampin/therapeutic use , Rural Health , Rural Population , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...